Larimar Therapeutics (LRMR) Interest Coverage Ratio: 2014-2020
Historic Interest Coverage Ratio for Larimar Therapeutics (LRMR) over the last 6 years, with Mar 2020 value amounting to -11.84.
- Larimar Therapeutics' Interest Coverage Ratio rose 55.42% to -11.84 in Q1 2020 from the same period last year, while for Mar 2020 it was -22.94, marking a year-over-year increase of 24.20%. This contributed to the annual value of -25.85 for FY2019, which is 19.72% up from last year.
- As of Q1 2020, Larimar Therapeutics' Interest Coverage Ratio stood at -11.84, which was up 41.15% from -20.11 recorded in Q4 2019.
- In the past 5 years, Larimar Therapeutics' Interest Coverage Ratio registered a high of -11.84 during Q1 2020, and its lowest value of -1,669.75 during Q4 2017.
- Over the past 3 years, Larimar Therapeutics' median Interest Coverage Ratio value was -29.44 (recorded in 2018), while the average stood at -27.04.
- Per our database at Business Quant, Larimar Therapeutics' Interest Coverage Ratio crashed by 1,446.21% in 2017 and then surged by 98.24% in 2018.
- Over the past 5 years, Larimar Therapeutics' Interest Coverage Ratio (Quarterly) stood at -107.99 in 2016, then plummeted by 1,446.21% to -1,669.75 in 2017, then skyrocketed by 98.24% to -29.44 in 2018, then spiked by 31.68% to -20.11 in 2019, then spiked by 55.42% to -11.84 in 2020.
- Its Interest Coverage Ratio stands at -11.84 for Q1 2020, versus -20.11 for Q4 2019 and -30.30 for Q3 2019.